Lisata Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Lisata Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Lisata Therapeutics Inc
Rating: 1.39933325
Author: Trendlyne DVM scores

about

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed...

2.08 0.11 (5.58%)

49.39% Fall from 52W High

34,776

XNAS Volume

XNAS 12 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

18.8 / 100

Technically Neutral

37.1 / 100

1Yr Price target upside is 525%

3 analysts

Lisata Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lisata Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed...

49.39% Fall from 52W High

SWOT Analysis

Lisata Therapeutics Inc Live Price Chart